(Q46587153)

English

Weekly docetaxel and zoledronic acid every 4 weeks in hormone-refractory prostate cancer patients.

scientific article published on 5 November 2005

Statements

Weekly docetaxel and zoledronic acid every 4 weeks in hormone-refractory prostate cancer patients. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit